Life Sciences Future Program 2016
October 25 – 26, 2016 Sheraton Downtown Philadelphia, PA
#LSF16
DAY 1
Schedule at-a-glanceå TIME
11:30AM – 1:00PM
11:30AM - 6:30PM
12:00PM - 1:00PM
1:00PM – 2:00PM
2:00PM – 5:30PM
5:30 PM – 6:30 PM
EVENT / LOCATION
Lunch, Registration and Scientific Posters Session Liberty Ballroom Foyer and Ballroom B
Realty Village Exhibits Liberty Ballroom Foyer
Scientific Poster Presentations and Review Liberty Ballroom B
Plenary Session - IBM Watson
How Data and Cognitive Insight will Transform the Life Sciences Landscape Liberty Ballroom C/D
Reverse Pitch Presentations Liberty Ballroom A
Informational Presentations Liberty Ballroom C/D
Cocktail Reception and Scientific Poster Session Liberty Ballroom B
#lsf16 wifi WIFI Network: LSF16 WIFI Password: LehighValley
2 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
DAY 2
Schedule at-a-glance TIME
7:15AM - 8:45AM
7:30AM - 8:45AM
9:00AM - 10:15AM
10:25AM - 11:15AM
11:15AM - 12:15AM
12:15PM - 1:45PM
1:55PM - 3:45PM
3:45PM - 4:45PM
3:30PM - 5:00PM
EVENT / LOCATION
Registration and Welcome Breakfast Liberty Ballroom Foyer and Ballroom B
Breakfast in the C-Suite (invitation only) Horizons Ballroom
Plenary Session - Combating Zika Global Preparedness Starts in PA Liberty Ballroom C/D
Company Presentations
Short Takes
Funding Meet-Ups
Short Takes
Liberty Ballroom Foyer
Liberty Ballroom Foyer
Liberty Ballroom A
Liberty Ballroom A
Lunch Plenary Session Featured Presentation Rare Diseases Liberty Ballroom C/D
Company Presentations
Short Takes
Funding Meet-Ups
Short Takes
Liberty Ballroom Foyer
Liberty Ballroom Foyer
Liberty Ballroom A
Liberty Ballroom A
Ice Cream Social Ballroom B
#LSF16 | 3
NOTES:
4 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Life Sciences Future 2016
Table of Contents SCHEDULE
2
WELCOME LETTER
6
SPONSORS
8
DAY 1 AGENDA
10
DAY 1 MAP
11
DAY 1 FEATURED SPEAKER
13
DAY 1 SPEAKERS
16
COMPANIES REVERSE PITCH
20
EXHIBITORS LIST
22
DAY 2 AGENDA
24
DAY 2 MAP
26
DAY 2 FEATURED SPEAKERS
28
DAY 2 SPEAKERS
34
COMPANY PRESENTATIONS
40
FUNDING MEET–UPS
44
SPONSORS – COMPANY DESCRIPTIONS
47
VOLUNTEERS
70
COMMITTEES
72
BOARD OF DIRECTORS
74
#LSF16 | 5
Welcome to Philadelphia and Life Sciences Future LIFE SCIENCES FUTURE was created to bring together
our diverse membership and the broader community of life sciences stakeholders
in the Mid-Atlantic region.
This year’s conference was developed to reflect the
interdependencies inherent in
the new healthcare environment – between academic research, entrepreneurs, industry,
investors, government and, ultimately, patients. This is
a conference focused on the
newest scientific advancements while looking into the future of our industry.
October 25, the opening day of Life Sciences Future, features
our symposium, Partnerships in Science, created to put research institutions, early to midstage companies, and business development teams in the same room to forge relationships that could lead to business opportunities. The event is designed for investors, research institutions, and individuals involved in biotechnology,
6 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
LIFE SCIENCES FUTURE
The Life Sciences Future
Thank you for your ongoing
partnering system and mobile
support.
app provide conference attendees the most advanced methods to connect easily by creating and reviewing profiles and arranging one-on-one and group meetings. The partnering
All the best,
Stephen Simpson Chairman, Life Sciences Future Partner, Strategic Growth Markets, Ernst & Young
system allows you to grow your connections beyond the Stephen Simpson
Christopher P. Molineaux
conference‌in the palm of your hand.
Christopher P. Molineaux President & CEO Pennsylvania Bio
Thank you to all our sponsors. pharmaceuticals, medical devices, diagnostics, healthcare IT and digital health. October 26 begins with Breakfast in the C-Suite for our chief executives, with special guest Todd Komarnicki, the writer of Sully, the Untold Story of the Miracle on the Hudson. Following Breakfast in the C-Suite is our Opening Keynote Address, IBM Watson - How Data and Cognitive Insight will Transform the Life Sciences Landscape, led by Louisa Roberts, Associate Partner and Solution Executive for IBM
Your continuing commitment to the life sciences industry helps to build a community that supports and nurtures the growth of our companies. We also are indebted to our incredible volunteer corps who have worked unselfishly for months to direct the conference content and make the event possible. Finally, we thank each of you. We hope you will learn something new, make new friends, and forge strategic connections as we all work toward advancing the future of the industry.
Watson Life Sciences.
#LSF16 | 7
Sponsors THANK YOU TO OUR 2016 SponsorS AON Corporation
Merck
AstraZeneca
Morgan Lewis
B. Braun
Pepper Hamilton
Biotechnology Innovation Organization
Pfizer
Bristol-Myers Squibb
PHL Life
The Children’s Hospital of Philadelphia
PhRMA
CliftonLarsenAllen
Pitch360
CSL Behring
ProTecs
DePuy Synthes
Rendering Real
Drexel University
Rowan University School of Osteopathic Medicine
Duane Morris
The Sarian Group at HighTower Advisors
EisnerAmper
Saul Ewing
Ernst & Young
ShareVault
Fisher Scientific
Shire
Garman Decal
Teleflex
GlaxoSmithKline
Temple University
The Hankin Group
Teva
The Higgins Group
Thomas Jefferson University
Hogan Lovells
University City Science Center
HVH Patient Precision Analytics
University of the Sciences
Janssen Biotech
University of Pennsylvania
Johnson & Johnson Innovation - JJDC
University of Pittsurgh
KPMG
Vertex
Lilly
The Wistar Institute
Lehigh Valley Economic Development Corporation Maguire Hayden Real Estate Company
8 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Aon Risk Solutions
You focus on innovation, we’ll focus on you The BIO Executive Liability Protection Panel gives BIO members access to expansive coverage offerings and competitive pricing from leading D&O insurers with a record of meeting the needs of life sciences companies. Let us help you empower results for your organization. To learn more, contact Jack Reick, Senior Vice President at jack.reick@aon.com, or Jim Walters, Life Sciences National Practice Leader at james.walters@aon.com. A proud sponsor of the Life Sciences Future Conference. aon.com/philly Risk. Reinsurance. Human Resources.
Partnering for scientific leadership At AstraZeneca, we believe in the power of what science can do to transform serious diseases like cancer, heart disease, diabetes, COPD and asthma. We also know that breakthrough science doesn’t happen in isolation. It happens through partnership.
Our expertise spans the entire life-cycle of a medicine and we have a rare combination of discovery and development strengths in small molecules and biologics, immunotherapies, protein engineering technologies and devices. These are reinforced by a strong focus on translational science and personalised healthcare.
To find out more, visit astrazeneca.com/Partnering
What science can do Circulating tumour DNA AstraZeneca has pioneered the use of circulating tumour DNA (ctDNA) in the diagnosis of cancer. Pieces of DNA break off from a tumour and circulate in the bloodstream where they can be analysed to give genetic information about a patient’s tumour. This allows healthcare professionals to determine the right treatment for the patient using a noninvasive blood test.
Atlas approval ID: 999,822.011 Expires August 2017
#LSF16 | 9
Day 1 | Agenda TIME
LIBERTY BALLROOM
11:30AM – 1:00PM
Lunch, Registration and Scientific Posters Session
11:30AM - 6:30PM
Realty Village Exhibits (Liberty Foyer)
12:00PM - 1:00PM
Scientific Poster Presentations and Review
1:00PM – 2:00PM
Plenary Session - IBM Watson
How Data and Cognitive Insight will Transform the Life Sciences Landscape Louisa Roberts, Associate Partner and Solution Executive, IBM
2:00PM – 5:30PM
Simultaneous Afternoon Tracks (Two Stages) Ballroom A
Reverse Pitch Presentations
Ballroom C/D
Informational Presentations Universities as Drivers of Innovation
2:00PM – 3:00PM 2:15PM – 2:30PM
Pfizer
2:30PM – 2:45PM
DePuy Synthes
2:45PM – 3:00PM
Shire
3:00PM – 3:15PM
B. Braun
Laurie Actman, University of Pennsylvania Ken Blank, Ph.D., Rowan University Marc Malandro, Ph.D., CLP, RTTP, University of Pittsburgh Alan Naidoff, JD, Princeton University MOD: Kathryn Doyle, Saul Ewing
Physician Meet-Up @ 3:30PM - 5:00PM Horizons Ballroom 3:15PM – 3:30PM
Johnson & Johnson Innovation – JJDC
3:30PM – 3:45PM
Merck
3:50PM – 4:05PM
GlaxoSmithKline
4:05PM – 4:20PM
Teleflex
Case Study in Open Innovation Network: Parker Institute for Cancer Immunotherapy and Penn Medicine
Kevin Mahoney, Penn Medicine Jon Epstein, M.D., University of Pennsylvania Adam Kolom, Parker Institute for Cancer Immunotherapy MOD: Kathryn Doyle, Saul Ewing
4:20PM – 5:20PM 4:20PM – 4:35PM
Teva
4:35PM – 4:50PM
CSL Behring
4:50PM – 5:05PM
AstraZeneca
5:05PM – 5:20PM
Bristol-Myers Squibb
5:30 PM – 6:30 PM
Universities Providing Services
Matthew Moneck, Carnegie Mellon University Jean-Francois Jasmin, University of the Sciences Brian Slocum, Lehigh University Ron Wilson, Penn State University MOD: Domingos Silva, Saul Ewing
Cocktail Reception and Scientific Poster Session
10 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Day 1 | map
Tuesday October 25 2016
A
B
C
D
E
1
Beverage Station
1
8'
8' 8'
8' 8'
8' 8'
8'
50'-0"
Ballroom D
26° 2k
REALTY VILLAGE
26° 2k
19° 2k
26°
19° 2k
26° 2k
2k
2
2 t
ffe
Bu
LIBERTY BALLROOM C/D Plenary Session Stage
Ballroom C
3
3
Lobby Area
Airwall Open at Each End
Beverages
Buffet
Buffet
t
ffe Bu
LIBERTY BALLROOM B Scientific Posters Cocktail Reception
Airwall Open at ONE End 4
4
LIBERTY BALLROOM A REVERSE PITCHES REGISTRATION
REVERSE PITCH MEET-UP
5
5
#LSF16 | 11
1
Sheet
PA
Producti
Pro
Sheet T
Date: T Time: 1 File nam
Note Revision
Sheet S
FLEX Jo
Drawn b Pau Cell pau
Project M Pau Cell pau
DAY
PLE Sea
400
SHO
Sea
95 S
9 Hi
Because B. Braun
Patients are safer. Clinicians are protected. The environment is healthier. B. Braun Medical Inc. is proud to sponsor Life Sciences Future.
© 2016
B. Braun Medical Inc., Bethlehem, PA 16-5654 100416 KE
MC16-5654-Life Sciences Future_Sponsorship Ad_100416.indd 1
PARTNERING TO SPEED TRANSFORMATIONAL MEDICINES TO PATIENTS Combining passion, science and experience to deliver innovation together
www.bms.com | NYSE: BMY
12 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
10/5/2016 2:21:52 PM
Featured Speaker
DAY 1
1:00PM-2:00 PM | LIBERTY BALLROOM IBM Watson Health How Data and Cognitive Insight will Transform the Life Sciences Landscape
LOUISA ROBERTS TITLE: Associate Partner and Solution Executive COMPANY: IBM Louisa Roberts is an Associate Partner and Solution Executive for Watson Life Sciences working with Pharma / Biotech clients to identify areas where Watson’s cognitive computing capabilities and advanced analytics can be used to solve complex problems and realize business value. Louisa is currently working with multiple clients using Watson to accelerate discovery, optimize protocols for clinical trials and conduct next generation pharmacovigilance. Louisa is a Life Sciences Industry SME having focused her career in pharma, both in house at AstraZeneca and GSK and as an external consultant with IBM Global Business Services and most recently IDEA Pharma. Louisa has defined strategy and improved decision making in all business critical functions, including R&D, Manufacturing, New Product Development, Marketing, Managed Markets and Sales. Areas of Expertise: • Precision Medicine, Clinical Research & Development Strategy, Life Science Commercial Strategy, Market Access Strategy, Patient Engagement & Outreach, Health Economics and Outcomes Research, Pharmacovigilance, Real World Evidence, Predictive Analytics, Business Strategy & Innovation
#LSF16 | 13
affiliate opt-in campaign-ad.pdf
5
10/6/16
1:53 PM
BREAKTHROUGH SAVINGS C
M
LOCK IN YOUR DISCOUNTED RATE FOR BIO 2017 NOW
Y
CM
MY
CY
CMY
K
To show our appreciation for the members Pennsylvania Bio, we're offering an opportunity to lock in a discount on BIO 2017. Registration is not required at this point. Just submit a simple form to claim your discounted rate. It's that easy!
Visit convention.bio.org/PABio for an exclusive discount on BIO 2017! JUNE 19-22, 2017 • SAN DIEGO CONVENTION CENTER
14 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
BECAUSE A GREAT IDEA CAN COME FROM ANYWHERE Johnson & Johnson Innovation seeks to find the best science and technology, no matter where it is, to solve the greatest unmet needs of our time. We catalyze, support, and invest in highly differentiated early-stage innovations that may extend and improve lives everywhere. Through Johnson & Johnson Innovation – JJDC, Inc., the venture capital subsidiary of Johnson & Johnson, we provide seed funding for new companies, equity investments, value-add investment support, and even new company creation through investment syndication. Our goal: translate cutting edge ideas into healthcare solutions for patients.
Together we can transform patient care.
www.jnjinnovation.com
@jnjinnovation
your jumpstart to the innovation gateway.
Research conducted at Temple University has a tangible impact on the Philadelphia region, Pennsylvania and the world. As one of the nation's premier universities and Pennsylvania's newest top 100 research institution*, we serve as an engine of innovation–advancing knowledge, making discoveries and improving lives.
Discover the possibilities with us. changing lives through research innovation. Visit us at research.temple.edu * based on NSF FY 2013 rankings
#LSF16 | 15
DAY 1
speakers LAURIE ACTMAN TITLE: CHIEF OPERATING OFFICER ORGANIZATION: Penn Center for Innovation
2:00PM – 3:00PM | STAGE 2 – LIBERTY BALLROOM
| Universities as Drivers of Innovation
KENNETH J. BLANK, PH.D. TITLE: SENIOR VICE PRESIDENT FOR HEALTH SCIENCES ORGANIZATION: Rowan University
2:00PM – 3:00PM | STAGE 2 – LIBERTY BALLROOM
| Universities as Drivers of Innovation
MARC MALANDRO, PH.D., CLP, RTTP TITLE: FOUNDING DIRECTOR - ASSOCIATE CHANCELLOR FOR TECHNOLOGY MANAGEMENT & COMMERCIALIZATION ORGANIZATION: University of Pittsburgh Innovation Institute 2:00PM – 3:00PM | STAGE 2 – LIBERTY BALLROOM
| Universities as Drivers of Innovation
ALAN NAIDOFF, JD TITLE: OFFICE OF THE DEAN FOR RESEARCH ORGANIZATION: Princeton University 2:00PM – 3:00PM | STAGE 2 – LIBERTY BALLROOM
| Universities as Drivers of Innovation
KEVIN MAHONEY TITLE: EXECUTIVE VICE PRESIDENT AND CHIEF ADMINISTRATIVE OFFICER ORGANIZATION: University of Pennsylvania Health System 3:15PM – 4:15PM | STAGE 2 – LIBERTY BALLROOM Case Study in Open Innovation Network: Parker Institute for Cancer Immunotherapy and Penn Medicine
JON EPSTEIN, M.D. TITLE: WILLIAM WIKOFF SMITH PROFESSOR, EXECUTIVE VICE DEAN AND CHIEF SCIENTIFIC OFFICER ORGANIZATION: Perelman School of Medicine, University of Pennsylvania 3:15PM – 4:15PM | STAGE 2 – LIBERTY BALLROOM Case Study in Open Innovation Network: Parker Institute for Cancer Immunotherapy and Penn Medicine
16 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
DAY 1 ADAM KOLOM TITLE: CO-FOUNDER ORGANIZATION: Parker Institute for Cancer Immunotherapy 3:15PM – 4:15PM | STAGE 2 – LIBERTY BALLROOM Case Study in Open Innovation Network: Parker Institute for Cancer Immunotherapy and Penn Medicine
BRIAN SLOCUM TITLE: MANAGING DIRECTOR, DESIGN LABS AND WILBUR POWERHOUSE ORGANIZATION: Lehigh University 4:15PM - 5:30PM | LIBERTY BALLROOM—STAGE 2 | Universities Providing Services
RON WILSON, VMD TITLE: DIRECTOR, PENN STATE HERSHEY ANIMAL RESOURCE PROGRAM ORGANIZATION: Penn State University 4:15PM - 5:30PM | LIBERTY BALLROOM—STAGE 2 | Universities Providing Services
JEAN-FRANCOIS JASMIN, PH.D. TITLE: ASSOCIATE PROFESSOR, DEPARTMENT OF PHARMACEUTICAL SCIENCES ORGANIZATION: University of the Sciences 4:15PM - 5:30PM | LIBERTY BALLROOM—STAGE 2 | Universities Providing Services
MATTHEW MONECK, PH.D. TITLE: EXECUTIVE MANAGER, NANOFABRICATION FACILITY ORGANIZATION: Carnegie Mellon University 4:15PM - 5:30PM | LIBERTY BALLROOM—STAGE 2 | Universities Providing Services
LEARN MORE ABOUT OUR SPEAKERS! VISIT LIFESCIENCESFUTURE.COM/SPEAKERS
#LSF16 | 17
DAY 1
PHYSICIAN MEET-UP
3:30PM-5:00PM | HORIZONS BALLROOM Physician Meet-Up (by invitation only)
PATRICK J. BRENNAN, M.D. TITLE: Chief Medical Officer ORGANIZATION: University of Pennsylvania
3:30PM - 5:00PM | HORIZONS BALLROOM | Physician Meet-Up (by Invitation Only)
TARA GRABOWSKY, M.D. TITLE: Chief Medical Officer ORGANIZATION: HVH Patient Precision Analytics
3:30PM - 5:00PM | HORIZONS BALLROOM | Physician Meet-Up (by Invitation Only)
KEN MORGENSTERN, M.D. TITLE: Founder ORGANIZATION: Morgenstern Center 3:30PM - 5:00PM | HORIZONS BALLROOM | Physician Meet-Up (by Invitation Only)
CLARENCE YOUNG, M.D. TITLE: Chief Medical Officer ORGANIZATION: Velicept Therapeutics, Inc. 3:30PM - 5:00PM | HORIZONS BALLROOM | Physician Meet-Up (by Invitation Only)
18 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
We advance the health of children by turning scientific discovery into medical innovation. The Childrenʼs Hospital of Philadelphia Research Institute is one of the largest pediatric research programs in the world. Our research and expertise have led to advancements in preventative care as well as treatments for nearly a century. To learn more, please visit our website at http://www.research.chop.edu and subscribe to our blog at http://blog.research.chop.edu
Are you connected to the resources you need? When entrepreneurs find themselves with more questions than answers, they look for help. Choosing a business structure, raising money, tapping legal, valuation or tax advice, and sometimes just talking to someone who’s “been there.” That’s where EisnerAmper fits in. Our passion is connecting entrepreneurs with the resources they need, when they need them, at every stage of the company’s life cycle. Wherever you are on your entrepreneurial journey, make one of your first connections to EisnerAmper.
Learn more at EisnerAmper.com/CONNECTED
Let’s get down to business.® eisneramper.com 215.881.8800 #LSF16 | 19
Reverse Pitch PRESENTATIONS DATE: OCTOBER 25, 2016 TIME: 2:15pm – 5:15pm LOCATION: LIBERTY BALLROOM / BALLROOM A
2:15PM - 2:30PM Pfizer
3:00PM - 3:15PM B. Braun
2:30PM - 2:45PM Depuy Synthes
3:15PM - 3:30PM
2:45PM - 3:00PM Shire
3:30PM - 3:45PM Merck & Co.
NOTES
20 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Johnson & Johnson Innovation
participating research institutions Cabrini University Carnegie Mellon University The Children’s Hospital of Philadelphia Columbia University Drexel University College of Medicine Drexel University Emory University Fox Chase Cancer Center Johns Hopkins University La Salle University Lafayette College Lehigh University
Northwestern University Penn State University Philadelphia College of Osteopathic Medicine Princeton University Rowan University Rowan University School of Osteopathic Medicine Temple University The Wistar Instititue Thomas Jefferson University University of Delaware
University of Pennsylvania University of Pittsburgh University of Pittsburgh Medical Center University of the Sciences Villanova University Ursinus College Wake Forest University Widener University
3:50PM - 4:05PM GlaxoSmithKline
4:35PM - 4:50PM CSL Behring
4:05PM - 4:20PM Teleflex
4:50PM - 5:05PM AstraZeneca
4:20PM - 4:35PM Teva
5:05PM - 5:20PM Bristol-Myers Squibb
NOTES
Day #LSF16 | 21
exhibitors october 26, 2016 - exhibit hall Adesis
PHL Life
Advanta Advertising Design
Sharevault
B. Braun
University of Pittsburgh
Alliance Pharma
The Brooks Group
AON Corporation
Pepper Hamilton
Biotechnology Innovation Organization
The FlexPro Group
Calvert Holdings
University City Science Center
CliftonLarsenAllen
PhRMA
CSL Behring
VerisVisalign
Cryopak CSL Behring
october 25, 2016 - Realty village
Duane Morris
Brandywine Realty Trust
EisnerAmper
Hayden REI
Elsevier
Liberty Property Trust
Epsilon Health
Pennovation
EveryLife Foundation
Pennsylvania Biotechnology Center
Fisher Scientific
Plexus Innovation Hub
HVH Patient Precision Analytics
ProTecs
IBM Watson Health
Rendering Real
Insperity
The Hankin Group
iPraxis
University City Science Center
KinderPharm
Wexford Science + Technology
Morgan Lewis Penn State University
Graphic Design Sponsor
Pepper Hamilton PhRMA (WeWorkforHealth) Reaction Biology Corp Saul Ewing
22 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Our promise has never been stronger. Using the latest technologies we are unlocking the potential of biotherapies to save lives. Engaging with patients worldwide, we continue to introduce new innovations that address unmet medical needs or enhance current treatments for people living with rare and serious conditions.
#LSF16 | 23
Day 2 | Agenda 7:30AM – 8:45 AM | BALLROOM B
Welcome Breakfast 7:30AM – 8:45 AM | HORIZONS BALLROOM
Breakfast in the C-Suite (invitation only) Todd Komarnicki, Writer, Sully, the Untold Story of the Miracle on the Hudson
TIME
LIBERTY / BALLROOM FOYER
BALLROOM A
Plenary Session Featured Presentation Combating Zika: Global Preparedness Starts in PA 9:00AM – 10:15AM
Jon Heinrichs, Segment Head, Early Development Projects, Sanofi Pasteur J. Joseph Kim, Ph.D., President & CEO, Inovio Pharmaceuticals Barney S. Graham, M.D., Ph.D., Senior Investigator, Viral Pathogenesis Laboratory, National Institutes of Health MOD: Peter Loftus, Wall Street Journal
10:25AM - 11:15AM
Company Presentations
Short Takes
10:25AM – Carmell Therapeutics 10:35AM – BioMagnetic Solutions 10:45AM – PolyAurum 10:55AM – Ascend Biopharmaceuticals 11:05AM – Imago Systems
10:25AM – 10:45AM
How to Get My Attention as an Investor Bruce Peacock, SV Life Sciences 10:50AM – 11:10AM
Overcoming Challenges in Forming Successful Collaborations Todd Sherer, Ph.D., Emory University
Funding Meet-Ups
11:15 AM – 12:15PM
BioAdvance 1315 Capital CapGenic Advisors Domain Associates Life Sciences Greenhouse - Central PA PCOM (Primary Care Innovation Fund) Ben Franklin Technology Partners of SEPA BIRD Foundation Pennsylvania Department of Community and Economic Development
Merck HighBank SV Life Sciences Advisors Blue Tree Allied Angels Mid-Atlantic Bio Angels Aisling Capital venBio Partners
24 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
11:15AM – 11:35AM
Making Clear the Value and Actual Costs of Medicines Holly Campbell, PhRMA 11:40AM-12:00PM
Immuno-oncology – What Will Separate the Winners from the Losers? John Carroll, Endpoints News
Wednesday October 26
Day 2 | Agenda
2016
TIME
LIBERTY / BALLROOM FOYER
BALLROOM A
Lunch Plenary Session Featured Presentation A Discussion on Rare Diseases
Dennis Jackman, Senior Vice President, Global Healthcare Policy and External Affairs, CSL Behring
12:15PM– 1:45PM
Monique Molloy, Executive Director, Orphan Disease Center, University of Pennsylvania Anthony J. Castaldo, President and Founding Member, Hereditary Angioedema International (HAEi) Gretta Stone, Director of Policy, PhRMA Tara Grabowsky, M.D., Chief Medical Officer, HVH Patient Precision Analytics MOD: Matt Cabrey, Executive Director, Select Greater Philadelphia
Short Takes 1:55PM – 2:15PM
How (and Why) to Win Government Grants
Company Presentations
1:55PM – 3:45PM
1:55PM – Intact Vascular 2:05PM – BluePen Biomarkers 2:15PM - PuriCore 2:25PM - PainQx 2:35PM – ImMAGE Biotherapeutics 2:45PM – AbiliLife 2:55PM – PeriRx 3:05PM - Incintas 3:15PM –QuiO 3:25PM – Arctic Therapeutics 3:35PM – Symbiotic Health
Christopher Burns, Ph.D., VenatoRx
2:20PM – 2:40PM
NCI’s Blue Ribbon Panel The Cancer Moonshot Initiative
Peter Adamson, M.D., Children’s Hospital of Philadelphia
2:45PM – 3:05PM
Why in the World Are We Moving Away from Developing Antibiotics? We Need Them More Than Ever! Evan Loh, M.D., Paratek Pharmaceuticals 3:10PM – 3:30PM
Thomas Jefferson’s 3rd Pillar - Innovation
Robin Sheldon, JD, Thomas Jefferson University 3:35PM – 3:55PM
Personalized Medicine and Genetic Diagnosis – Hurdles and Challenges
Funding Meet-Ups 3:45PM – 4:45PM
Fidem Capital Harding Loevner Johnson & Johnson Innovation - JJDC Palo Alto Investors MPM Capital IP Group
Natalie Cummins, Genomind
SCP Vitalife Partners Park Ave Capital NSIP LLC SG3 Ventures Ridgetop Health Innovation Works
4:00PM – 4:20PM
What Works, and What Doesn’t When it Comes to Using Presentations to Persuade an Audience Patricia Scott, Ph.D., Uhmms
3:30PM - 5:00PM | BALLROOM B
ICE CREAM SOCIAL
#LSF16 | 25
MAP | DAY 2
Life Sciences Future
26 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
1
Ballroom D
Ballroom C
Airwall Open at Each End
3
Lobby Area
3
Beverages
Buffet
Refreshments Buffet
EXHIBIT HALL
2
COMPANY PRESENTATIONS
COMPANY PRESENTATIONS
LIBERTY BALLROOM C/D Plenary Session Stage 2
4
4
SHORT TAKES FLU SHOTS
2k 2k 2k
26° 26° 19° 19° 26° 26°
2k 2k 2k
8' 8' 8' 8' 8' 8' 8' 8'
A
FUNDING MEET-UPS
B
C
D
E
1
50'-0"
Airwall Open at ONE End
REGISTRATION
5
5
Sheet #
1.1
October-2016
PA Bio Life Sciences Future
Production Info:
Liberty Balroom
Sheraton City Center
Production Plot [24" x 36"]
Sheet Title:
Note: Date: Update Data Stamp prior to printing or exporting sheet layers Revision
1/16" = 1'0"
Date: Tue, Oct 18, 2016 Time: 10:21:48 AM File name: 2015.10 - PA Biotech Life Sciences Future.vwx
Sheet Scale:
FLEX Job #:
Drawn by: Paul Kennealy Cell: (610) 636-3515 paul.kennealy@advancedstaging.com
Project Manager: Paul Kennealy Cell: (610) 636-3515 paul.kennealy@advancedstaging.com
DAY 2
PLENARY STAGE
Seating Layout
10 - 30" Rounds of 5
30- 72" Rounds of 10
350 Seats Total
SHORT TAKES STAGE
Seating Layout
100 Seats - Theater
9 High Cocktail Rounds
DAY 2
Featured Speakers
7:30AM-9:00AM | HORIZON BALLROOM Breakfast in the C-Suite (Invitation Only)
TODD KOMARNICKI TITLE: WRITER SULLY, THE UNTOLD STORY OF THE MIRACLE ON THE HUDSON TODD KOMARNICKI is a prolific writer, producer and director of film and television as well as an acclaimed novelist. His first novel, Free, was published by Doubleday in 1993 and his second novel, famine (Arcade 1997), received tremendous reviews and was subsequently translated into French, Italian, and German. His third novel, war, was published to exceptional reviews in July of 2008 by Arcade. In addition to his accomplishments in the literary world, Komarnicki has also found success in the entertainment industry as the director of the international production, RESISTANCE, starring Julia Ormond and Bill Paxton, which Komarnicki adapted from an Anita Shreve novel. This World War II epic love story was released in 2003 and is currently available on DVD worldwide from Paramount and Lionsgate Entertainment. Komarnicki’s screenplays include SULLY directed by Clint Eastwood and starring Tom Hanks, which opened at #1 in the box office to rave reviews from critics and audiences alike. Komarnicki has also written PERFECT STRANGER starring Bruce Willis and Halle Berry, an adaptation of the international bestseller; THE PROFESSOR AND THE MADMAN, which is set to go into production starring Mel Gibson and Sean Penn; THE GREATEST GIFT, the true story behind the film classic, IT’S A WONDERFUL LIFE. Komarnicki is set to direct THE GOD FOUR in 2017, which he adapted from the novel Flat Water Tuesday. He has also sold pilots to ABC, NBC, CBS, FOX, and TNT. Komarnicki is the president & founder of the production/management company Guy Walks Into A Bar. Komarnicki and Guy Walks partner Jon Berg produced the Christmas blockbuster ELF, starring Will Ferrell and directed by Jon Favreau. The film amassed over $220 million worldwide, and has become a perennial favorite every Christmas season. He is represented by CAA (Creative Artists Agency). Komarnicki lives in New York City with his wife, Jane, and their daughter, Remy, and son, Dashiell.
28 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
DAY 2 9:00AM - 10:15AM | LIBERTY BALLROOM PLENARY SESSION: Combating Zika: Global Preparedness Starts in PA
BARNEY S. GRAHAM, M.D., PH.D. TITLE: SENIOR INVESTIGATOR, VIRAL PATHOGENESIS LABORATORY ORGANIZATION: National Institutes of Health (NIH) Dr. Graham is an immunologist, virologist, and clinical trials physician whose primary interests are viral pathogenesis, immunity, and vaccine development. His work is focused on HIV, respiratory syncytial virus (RSV), and emerging viral diseases. He has been involved in the clinical evaluation of candidate HIV vaccines for more than 25 years and has an ongoing interest in science education and expanding research opportunities for African-Americans and other under-represented minorities. After graduating magna cum laude from Rice University, he obtained his M.D. from the University of Kansas School of Medicine in 1979. He then completed residency and two chief residencies in internal medicine, a fellowship in infectious diseases, and a Ph.D. in microbiology and immunology at Vanderbilt University School of Medicine, where he rose to the rank of professor of medicine with a joint appointment in the department of microbiology and immunology. In 2000, he became one of the founding investigators for the NIAID Vaccine Research Center, where he is chief of the Viral Pathogenesis Laboratory and Clinical Trials Core. He is a member of the American Society for Clinical Investigation and the American Association of Physicians and a fellow of the Infectious Disease Society of America and the American Academy of Microbiology. He has served on editorial boards for theJournal of Biological Chemistry, Journal of Virology, Journal of Infectious Diseases, and Journal of AIDS and is a member of scientific advisory boards for organizations involved in HIV, RSV, malaria, and TB vaccine development.
#LSF16 | 29
DAY 2
Featured Speakers
9:00AM-10:15AM | LIBERTY BALLROOM PLENARY SESSION: Combating Zika: Global Preparedness Starts in PA
JON HEINRICHS, PH.D. TITLE: SEGMENT HEAD, EARLY DEVELOPMENT PROJECTS ORGANIZATION: Sanofi Pasteur Jon Heinrichs is an Associate Vice President and Segment Head in Global Project Leadership at Sanofi Pasteur in Swiftwater, PA where he leads vaccine projects in the Pre-Development and Early Development spaces. Prior to joining Sanofi, Dr. Heinrichs headed the Microbial Vaccine Research group at Merck Research Labs where he led a team of scientists developing vaccines for several bacterial pathogens including Clostridium difficile, Staphylococcus aureus, Streptococcus pneumoniae, and Chlamydia trachomatis.
J. JOSEPH KIM, PH.D. TITLE: PRESIDENT & CHIEF EXECUTIVE OFFICER ORGANIZATION: Inovio Pharmaceuticals J. Joseph Kim, Ph.D., President, Chief Executive Officer, Director at Inovio Pharmaceuticals. Joseph Kim was appointed President and CEO of Inovio Pharmaceuticals in June 2009. Dr. Kim co-founded VGX Pharmaceuticals, a synthetic vaccine company in 2000 to develop intellectual property related to immunotherapeutics licensed from the University of Pennsylvania. He led the company for nine years and combined VGX with Inovio Biomedical in 2009 to form Inovio Pharmaceuticals. Inovio is revolutionizing the fight against cancers and infectious diseases. Their strategy is to focus on their core expertise, conducting R&D and clinical development to achieve proof of principle of their SynCon® immunotherapy products, and engage with partners to complete late-stage clinical development and commercialization and, in some cases, advance early-stage programs. Inovio has forged partnerships with pharma companies, government agencies and leading academic institutions to support the development of DNA-based immunotherapies delivered via Inovio’s electroporation technology in many disease areas.
30 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
DAY 2 9:00AM-10:15AM | LIBERTY BALLROOM PLENARY SESSION: Combating Zika: Global Preparedness Starts in PA
Moderator PETER LOFTUS TITLE: JOURNALIST ORGANIZATION: Wall Street Journal Peter Loftus has been a reporter for The Wall Street Journal covering the pharmaceutical industry and healthcare since 2013, based in the Philadelphia area. He previously wrote about those and other topics for Dow Jones Newswires, which he joined in 1997 in New York. Before that, he covered courts, politics and community news for The Reporter newspaper in Lansdale, Pa. He graduated from the University of Notre Dame in 1992 with a bachelor’s degree in English and history.
#LSF16 | 31
DAY 2
Featured Speakers
12:15PM-1:45PM | LIBERTY BALLROOM LUNCH PLENARY SESSION: Rare Diseases
ANTHONY J. CASTALDO TITLE: PRESIDENT & FOUNDING MEMBER ORGANIZATION: Hereditary Angioedema International (HAEi) Mr. Anthony Castaldo is the President and Founding Board Member of Hereditary Angioedema International (HAEi), an organization that represents the world’s HAE patient organizations. Under Mr. Castaldo’s leadership, the organization provides training and technical assistance to HAE groups looking to increase disease awareness, diagnosis, and access to life saving medicines. HAEi also works closely with patients who are interesting in starting a HAE organization in their country. He is also President and founding Board member of the US Hereditary Angioedema Association (HAEA)—an advocacy, patient services, and research organization with more than 5,800 members. Over the years, Mr. Castaldo led the US HAEA’s transformation into an ambitious and effective a nationwide advocacy movement focused on increasing HAE awareness and education, driving continuous improvement in HAE care, empowering patient access to an optimal therapy, maintaining a strong presence in the legislative and health care policy arenas, and fostering groundbreaking research. While vigorously pursuing his HAE advocacy activities, Mr. Castaldo served as the Associate Inspector General for the United States Federal Reserve until retiring in 2013. He has been listed as a co-author on 13 HAE medical journal publications.
TARA GRABOWSKY, M.D. TITLE: CHIEF MEDICAL OFFICER ORGANIZATION: HVH Patient Precision Analytics Dr. Tara Grabowsky is the Chief Medical Officer at HVH Patient Precision Analytics. She worked for over a decade as an internist in academic, underserved, and private practice settings. In 2014, she transitioned from practice to her career in clinical analytics. She also writes the corporate blog and speaks frequently. She has won numerous teaching awards for her instruction of Harvard medical students, interns, and residents. She worked previously for Johnson & Johnson in its regulatory affairs department. She graduated with honors from Dartmouth College, attended Stanford Medical School, and completed her internal medicine residency at Harvard’s Brigham and Women’s Hospital.
32 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
DAY 2 12:15PM-1:45PM | LIBERTY BALLROOM LUNCH PLENARY SESSION: Rare Diseases
MONIQUE MOLLOY TITLE: EXECUTIVE DIRECTOR, ORPHAN DISEASE CENTER ORGANIZATION: University of Pennsylvania Monique Molloy serves as the Executive Director of the Orphan Disease Center at Penn Medicine, a role she took on in 2014. The mission of the Orphan Disease Center is to apply novel therapeutic platforms across a broad array of rare diseases focusing on those with substantial unmet need. The team at the Orphan Disease Center works with over 30 rare disease patient advocacy groups to raise money, advance translational research, and partner programs with biotech/pharma. In addition, Monique serves as the Executive Director of Research Administration for the Gene Therapy Program at Penn, which is capable of translating discoveries into proof-of-concept first in human studies. She has over 20 years of experience providing administrative support to this research effort which currently includes 5 biopharmaceutical alliances and is largely focused on orphan diseases. Monique has a BS in Biology from Villanova University.
GRETTA STONE TITLE: DIRECTOR OF POLICY ORGANIZATION: PhRMA Gretta Stone is a Director of Policy at PhRMA. Gretta received her undergraduate degree from Georgetown University.
Moderator MATTHEW CABREY TITLE: EXECUTIVE DIRECTOR ORGANIZATION: Select Greater Philadelphia As Executive Director of Select Greater Philadelphia, Matt leads the region-wide team effort to market the 11-county neighborhood of northern Delaware, southern New Jersey, and southeastern Pennsylvania to a national and international audience as a top-tier place to establish and grow a business. #LSF16 | 33
DAY 2
Speakers BRUCE PEACOCK TITLE: VENTURE PARTNER ORGANIZATION: SV Life Sciences, LLC
10:25AM-10:45AM | BALLROOM A | How to Get My Attention As An Investor
TODD SHERER, PH.D. TITLE: ASSOCIATE VICE PRESIDENT AND DIRECTOR, OFFICE OF TECHNOLOGY TRANSFER ORGANIZATION: Emory University 10:50AM-11:10AM | BALLROOM A | Overcoming Challenges in Forming Successful Collaborations
HOLLY CAMPBELL TITLE: SENIOR DIRECTOR, COMMUNICATIONS ORGANIZATION: PhRMA 11:15AM-11:35AM | BALLROOM A | Making Clear the Value and Actual Cost of Medicine
JOHN CARROLL TITLE: EDITOR, CO-FOUNDER ORGANIZATION: Endpoints News 11:40AM-12:00PM | BALLROOM A Immuno-oncology – What Will Separate the Winners from the Losers?
CHRISTOPHER BURNS, PH.D. TITLE: PRESIDENT AND CHIEF SCIENTIFIC OFFICER ORGANIZATION: VenatoRx 1:55PM-2:15PM | BALLROOM A | How (and Why) to Win Government Grants
PETER ADAMSON, M.D. TITLE: CHAIR, CHILDREN’S ONCOLOGY GROUP, ALAN R. COHEN ENDOWED CHAIR IN PEDIATRICS ORGANIZATION: The Children’s Hospital of Philadelphia 2:20PM-2:40PM | BALLROOM A | NCI’s Blue Ribbon Panel - The Cancer Moonshot Initiative
34 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
DAY 2 EVAN LOH, M.D. TITLE: PRESIDENT AND CHIEF MEDICAL OFFICER ORGANIZATION: Paratek Pharmaceuticals
2:45PM-3:05PM | BALLROOM A Why in the World Are We Moving Away from Developing Antibiotics? We Need them More than Ever!
ROBIN SHELDON, JD TITLE: VICE PRESIDENT, INNOVATION MANAGEMENT ORGANIZATION: Thomas Jefferson University 3:10PM-3:30PM | BALLROOM A | Thomas Jefferson’s 3rd Pillar - Innovation
NATALIE CUMMINS TITLE: SENIOR VICE PRESIDENT, CHIEF STRATEGY OFFICER ORGANIZATION: Genomind 3:35PM-3:55PM | BALLROOM A Personalized Medicine and Genetic Diagnosis – Hurdles and Challenges
PATRICIA SCOTT, PH.D. TITLE: PRESIDENT, CHIEF EXECUTIVE OFFICER ORGANIZATION: Uhmms 4:00PM-4:20PM | BALLROOM A What Works, and What Doesn’t When it Comes to Using Presentations to Persuade an Audience
#LSF16 | 35
Building Towards the Future At GSK, our mission is to help patients do more, feel better and live longer. Through our business development efforts, we are constantly seeking opportunities to work with others to achieve this mission. Whether in our Pharmaceuticals, Vaccines, or Consumer Health business, GSK has experience across a diverse range of collaboration types, including:
• Early stage research collaborations
• Co-promotions
• Late stage licensing
• Acquisitions
Email us at ww.bd@gsk.com
36 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Helping you make the world healthier With 450 life sciences lawyers across the globe, we understand the issues you face in the countries you do business in, helping you to stay ahead of the curve. For additional information, visit:
www.hoganlovells.com/life-sciences @HLLifeSciences
Hogan Lovells is an international legal practice that includes Hogan Lovells US LLP and Hogan Lovells International LLP. Š Hogan Lovells 2016. All rights reserved.
#LSF16 | 37
Advertisement
38 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
It begins with a promise to discover medicines that make life better. Since 1876, we have worked tirelessly to discover medicines that make life better, finding ways to come through no matter the odds. From the development of insulin to the discovery of new treatments for mental illness, we have pioneered breakthroughs against some of the most stubborn and devastating diseases. We bring this same determination to our work today, uniting our expertise with the creativity of research partners across the globe to keep finding ways to make life better.
Hong Hu, Research Advisor, Lilly Research Laboratories
To find out more about our promise, visit www.lilly.com/promise. 2016 CA Approved for External Use PRINTED IN USA Š2016, Eli Lilly and Company. ALL RIGHTS RESERVED.
At Merck, we share your passion for developing breakthrough medicines, vaccines and technologies to advance human health. Inspired by novel approaches, we are forging unique partnerships with forward-thinking leaders around the world to bring innovations from bench to bedside. Merck seeks partnerships across all therapeutic areas and technologies. Learn more at merck.com/licensing
Working together because the world is waiting. Merck is known as MSD outside the United States and Canada. Copyright Š2015 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.
#LSF16 | 39
CompanY Presentations DATE: OCTOBER 26, 2016 SESSION 01: 10:25AM - 11:15AM | SESSION 02: 1:55PM - 3:45PM LOCATION: LIBERTY BALLROOM
10:25AM
10:55AM
1:55PM
Carmell
Ascend
Intact
10:35AM
11:05AM
2:05PM
BioMagnetic
Imago
BluePen
Therapeutics
Solutions
Biopharmaceuticals
Systems
Vascular
Biomarkers
10:45AM
2:15PM
PolyAurum
PuriCore
Day TWO
40 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
2:25PM PainQx
DAY 2
NOTES:
2:35PM
3:15PM
ImMAGE
QuiO
2:45PM
3:25PM
AbiliLife
Arctic
2:55PM
3:35PM
PeriRx
Symbiotic
Biotherapeutics
Therapeutics
Health
3:05PM Incintas
#LSF16 | 41
PHILADELPHIA A world-class life sciences meetings and conventions destination
A premier hub of life sciences activity, Philadelphia is both a leader in technology and innovation, as well as a city with a rich history of medical firsts. Our region boasts top leaders across all sectors of the industry—including academics, medicine, healthcare, biotechnology, pharmaceuticals, venture capital, nursing, and the business community—all helping to drive meeting attendance and deliver business goals. Add to that our central location and close proximity to more than 40 percent of the U.S. population, and you’ll see why Philadelphia truly is America’s Life Sciences Meetings Destination. We’re here to help! 1-855-MEET-PHL or PHLLifeSciences.com
Large Pharma Uses
ShareVault is the Biopharma Innovation Organization’s (BIO) secure document sharing solution of choice and is used by 44 of the top 45 global biopharma companies. We believe that secure document sharing for biopharma partnering and licensing should enhance partnerships with increased collaboration and trust and streamline due diligence to facilitate growth. Organizations that choose ShareVault include:
ShareVault.com 408.717.4955
The Penn Center for Innovation (PCI) helps to translate Penn discoveries and ideas into new products and businesses for the benefit of society. It does this by facilitating technology development connections between Penn and the private sector.
Penn Center for Innovation pci.upenn.edu
Whether the end result is a technology license, an R&D alliance, the formation of a new venture or an integrated combination of any or all of these activities, PCI serves as a dedicated onestop shop for commercial partnering with Penn.
PCI is proud to sponsor Life Sciences Future 2016!
The future begins here.
innovation.pitt.edu
Day TWO
Morning Funding Meet ups
DATE: OCTOBER 26, 2016 TIME: 11:15PM – 12:15PM LOCATION: LIBERTY FOYER
44 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Afternoon Funding Meet ups DATE: OCTOBER 26, 2016 TIME: 3:45PM – 4:45PM LOCATION: LIBERTY FOYER
PALO ALTO INVESTORS
PARK AVE CAPITAL
NSIP, LLC
NOTES:
#LSF16 | 45
Sponsors
ADVANCING
LIFE SCIENCES INNOVATION Morgan Lewis has built the capabilities to serve the complete life sciences product life cycle and all aspects of the healthcare and life sciences industry. We understand and work creatively to solve the business, transactional, regulatory, intellectual property, litigation, and related issues that our clients face along the product life cycle. INDUSTRY FOCUS AREAS INCLUDE:
AREAS OF LEGAL SERVICES INCLUDE:
Pharma and biotech Medical device Healthcare
Emerging growth and finance Intellectual property strategy Research and development Regulatory approval Pricing and reimbursement Global marketing and operations Litigation and investigations Collaborations and M&A
www.morganlewis.com This material is provided for your convenience and does not constitute legal advice or create an attorney-client relationship. Prior results do not guarantee similar outcomes. Attorney Advertising. Š 2016 Morgan, Lewis & Bockius LLP
46 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
For more information, please contact: Stephen A. Jannetta stephen.jannetta@morganlewis.com +1.215.963.5092
Sponsors AON CORPORATION Aon plc is the leading global provider of risk management, insurance and reinsurance brokerage, and human resources solutions and outsourcing services. Through its more than 72,000 colleagues worldwide, Aon unites to empower results for clients in over 120 countries via innovative and effective risk and people solutions and through industry-leading global resources and technical expertise. Aon has been named repeatedly as the world’s best broker, best insurance intermediary, best reinsurance intermediary, best captives manager, and best employee benefits consulting firm by multiple industry sources.
ASTRAZENECA AstraZeneca is a global, innovationdriven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas - respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology – as well as in infection and neuroscience. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
B. BRAUN B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®. Globally, the B. Braun Group of Companies employs more than 56,000 employees in more than 60 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com
#LSF16 | 47
Sponsors BIOTECHNOLOGY INNOVATION ORGANIZATION BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. Corporate members range from entrepreneurial companies developing a first product to Fortune 500 multinationals. We also represent state and regional biotech associations, service providers to the industry, and academic centers. Our members help foster a healthy economy by creating good-paying, biotechnology jobs. Not only do we advocate for our members, but we also work towards enriching the industry with networking, partnering and education opportunities. We organize the BIO International Convention, the global event for biotechnology, along with many other industry-leading investor and partnering events held around the world. In addition, we produce BIOtechNOW, an online portal and monthly newsletter chronicling ‘innovations transforming our world.’
BRISTOL-MYERS SQUIBB Bristol-Myers Squibb is a global biopharmaceutical company with a BioPharma strategy that uniquely combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a successful biotechnology company. Bristol-Myers Squibb is looking to identify innovative science and partners that can help us execute on our mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our priorities focus on core therapeutic areas where patients have high unmet medical need and where we believe we can deliver the greatest value to patients, including immunooncology, oncology, immunoscience, cardiovascular, fibrotic disease and genetically defined diseases. The company believes that finding the right partners is critical. Our team seeks to identify opportunities across the spectrum of drug development, from discovery to late stage clinical trials and commercialization. Bristol-Myers Squibb is flexible to location, size and design of our collaborations.
48 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Sponsors
CHILDREN’S HOSPITAL OF PHILADELPHIA With more than 525 investigators and a research staff in the thousands, The Children’s Hospital of Philadelphia Research Institute continues its groundbreaking basic, clinical, and translational research on childhood cancer, genetics, genomics, autism, pediatric heart disease, neuroscience, liver disease, rare and orphan diseases, and many other pediatric conditions and diseases.
CLIFTONLARSONALLEN CLA is a professional services firm delivering integrated wealth advisory, outsourcing, and public accounting capabilities to help clients succeed professionally and personally. This allows us to serve clients more completely and offer our people diverse career opportunities. We believe professional relationships can be personal and those connections can last for generations. You can depend on CLA for deep industry insight, seamless integrated capabilities, premier resource for private businesses and owners, and professionals personally invested in your success.
CSL BEHRING Starting a century ago, CSL made a promise to save lives and protect the health of people stricken with a range of serious and chronic medical conditions. Today that same promise has never been stronger. With operations in more than 60 nations and over 16,000 employees worldwide, CSL develops and delivers biotherapies to prevent and treat people with lifethreatening medical conditions. Our broad-range of therapies include those to treat disorders such as haemophilia and primary immune deficiencies, and vaccines to prevent influenza. We collaborate with patient and biomedical communities to improve access to therapies, advance scientific knowledge, and support future medical research. Our world-class commercial operation, combined with a large and focused R&D team and operational excellence, enable us to accurately identify, successfully develop, and dependably deliver innovations that patients and providers want. For a century, CSL has earned a reputation as a passionate yet responsible organization, driven to care for patients and deliver on its commitments.
#LSF16 | 49
50 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
#LSF16 | 50
Sponsors
REACH MORE PATIENTS. RESTORE MORE LIVES.
© Johnson & Johnson Services, Inc. 2016. All Rights Reserved.
#LSF16 | 51
Sponsors DREXEL UNIVERSITY Drexel is a comprehensive global research university ranked among the top 100 in the nation. With approximately 26,000 students, Drexel is one of America’s 15 largest private universities. Drexel has built its global reputation on core achievements that include: Leadership in experiential learning through Drexel Co-op; a history of academic technology firsts; and recognition as a model of best practices in translational, use-inspired research. Founded in 1891 in Philadelphia, Drexel now engages with students and communities around the world via three Philadelphia campuses and other regional sites; the Academy of Natural Sciences of Drexel University, the nation’s oldest major natural science museum and research organization; international research partnerships including China and Israel; and Drexel Online, one of the oldest and most successful providers of online degree programs.
DUANE MORRIS With experienced life sciences lawyers across our global platform, coupled with the deep capabilities of more than 750 lawyers across all practice areas, Duane Morris counsels on specific issues affecting the industry, including science and technology challenges, licensing, regulatory and compliance and due diligence. Our lawyers have decades of experience representing a variety of life sciences clients working in a broad range of technologies, including pharmaceuticals, biotechnology, medical devices and diagnostics, at all stages of the product life cycle, from discovery through clinical development and commercialization. Many of our life science attorneys have been in-house counsel at life sciences companies and/ or have worked as scientists in research laboratories. The practice group has been recognized as a global legal advisor for biotechnology and pharmaceutical licensing transactions and a top 10 law firm for the pharmaceutical industry, among other client service awards and accolades.
EISNERAMPER LLP EisnerAmper LLP is a leading accounting and advisory firm with offices in Philadelphia, as well as California, Massachusetts, New Jersey, New York, and elsewhere. Our Life Sciences professionals have the requisite expertise, resources and relationships to assist both public and private life sciences companies bridge the gap between business and science. EisnerAmper’s practice includes over 250 pharmaceutical, biotechnology medical device and related companies. Our commitment to the industry and the region is evidenced through our active involvement in and support of the national BIO organization, as well as local BIOs in Pennsylvania, New Jersey and New York. We work alongside investors (angels, venture capital and private equity) as well as law firms. We have the connections to see life science companies through their lifecycle from start-up to IPO.
52 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Sponsors ERNST & YOUNG We are 230,000 people based in 728 offices in 150 countries, organized into 28 Regions and four Areas. All of our people work in one of our service lines – Assurance, Advisory, Tax, Transaction Advisory Services (TAS) – or in Core Business Services (CBS) which provides internal operational support such as HR and IT services. EY is committed to doing its part in building a better working world. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities. Our values define who we are. They influence the way we work with each other, our clients and regulators, and our communities, where we use professional skills to create positive change close to home and around the world.
FISHER SCIENTIFIC Fisher Scientific is a part of ThermoFisher Scientific, Inc. and specializes in scientific research, laboratory testing and life science research. They provide the latest equipment and instrumentation, finest chemicals and highest-quality supplies.
GLAXOSMITHKLINE We are a science-led global healthcare company – with three world-leading businesses – that researches, develops and manufactures innovative pharmaceutical medicines, vaccines and consumer healthcare products. We are committed to widening access to our products, so more people can benefit, no matter where they live in the world or what they can afford to pay. We are on a mission to help people do more, feel better, and live longer. That’s why we are harnessing our scientific expertise, our partnerships and our global reach to develop and make medicines, vaccines and consumer healthcare products for people who need them. As a business we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them. Behaving responsibly does not compromise commercial success, but enables it. By doing what we do best, we can deliver strong, sustainable performance and help improve the lives of people all over the world. #LSF16 | 53
Sponsors THE HIGGINS GROUP Executive Search for the Life Sciences | The Higgins Group is a retained executive search firm dedicated to providing major and emerging companies in the life sciences with access to the leadership they need for exceptional market performance. Focus, Experience, Commitment | The Life Sciences are our sole focus: The Higgins Group client list includes pharmaceutical, biotech, medical device and diagnostics firms ranging from Fortune 500 companies to specialty pharma to venture backed start-ups, all requiring executives with dedicated leadership in the life sciences. The Higgins Group owner and founder Donna Higgins has almost three decades of experience in both emerging and large corporate life sciences environments. This rich industry experience provides insight into the demands of life sciences corporations, and is complimented by her dedicated focus on the right results, and a willingness to understand and put clients’ needs first.
HOGAN LOVELLS Navigating complexities in the life sciences and healthcare industries is no easy task. Successfully competing in the space requires increasingly creative strategies and integrated solutions that protect and support your business day in and day out. Regardless of the sector of the healthcare industry in which you operate or the maturity of your products, we understand how to bridge the gap between the challenges you face and the outcome you want. From budding startups to multinational enterprises, we’ve been there before and know how to position you for success. With more than 450 life sciences lawyers across the globe, we work closely with you and each other to tackle tough issues and difficult-to-enter markets – no matter where you are today or want to be tomorrow. And because we know what makes your industry tick, we have a deep understanding of the issues you face – helping you stay ahead of the curve and on top of your opportunities. Whatever your challenge, wherever the issue, Hogan Lovells has you covered. It’s that easy.
54 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Sponsors HVH PATIENT PRECISION ANALYTICS HVH combines the strengths of Havas Health, a strategic communications partner to many top biopharma companies, and Vencore, a leader in next-gen machine learning and advanced predictive analytics. At HVH, we are leveraging sophisticated analytics honed for decades in support of the intelligence community and folding in deep therapeutic-area expertise to rethink how to serve the rare and niche disease market. We have a unique ability to collect, aggregate, and analyze the journeys of known patients to inform early diagnosis and intervention of undiagnosed patients, helping you to maximize your ability to effectively reach patients.
Strategic PARTNERSHIP is at the heart of fulfilling Pfizer’s purpose as we work to translate advanced science and technologies into medicines and vaccines that significantly improve patients’ lives. Our R&D Focus Areas • CV and Metabolic • Immunology and Inflammation • Neuroscience & Pain • Oncology • Vaccine Research • Rare Disease • Biosimilars
www.pfizer.com/partnering
#LSF16 | 55
Sponsors JANSSEN At Janssen Biotech, Inc. we have an urgent commitment to make a difference in the lives of cancer patients and those living with autoimmune diseases. Comprised of Janssen Oncology and Janssen Immunology, we exercise scientific rigor and passion to deliver transformational biologic medicines to market, and in the process we have built a rich legacy of innovative firsts. Inspired to achieve the best possible health outcomes for patients, we also offer a full range of support services to ensure patients and their families, caregivers, advocates and health care professionals are empowered with the latest treatment information and quality care. Janssen Biotech, Inc. and Janssen Research & Development, LLC are part of the Janssen Pharmaceutical Companies of Johnson & Johnson. For more information visit www.janssen.com. Follow us on Twitter at www.twitter.com/ JanssenUS.
JOHNSON & JOHNSON INNOVATION - JJDC Executive Search for the Life Sciences | The Higgins Group is a retained executive search firm dedicated to providing major and emerging companies in the life sciences with access to the leadership they need for exceptional market performance. Focus, Experience, Commitment | The Life Sciences are our sole focus: The Higgins Group client list includes pharmaceutical, biotech, medical device and diagnostics firms ranging from Fortune 500 companies to specialty pharma to venture backed start-ups, all requiring executives with dedicated leadership in the life sciences. The Higgins Group owner and founder Donna Higgins has almost three decades of experience in both emerging and large corporate life sciences environments. This rich industry experience provides insight into the demands of life sciences corporations, and is complimented by her dedicated focus on the right results, and a willingness to understand and put clients’ needs first.
56 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Sponsors KMPG KPMG LLP’s (KPMG) Philadelphia office opened its doors in 1906 and ranks among the city’s oldest and most prominent professional services firms. A professional service firm with a strong growth record over the past decade, the Philadelphia office (including Radnor) is staffed with nearly 1,200 employees, and over 100 Audit, Tax, and Advisory partners who serve publicly and privately owned businesses throughout the region, country, and world.
LILLY Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring lifechanging medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/socialchannels.
LEHIGH VALLEY ECONOMIC DEVELOPMENT CORPORATION Lehigh Valley is a two-county region in eastern Pennsylvania consisting of 62 municipalities and three cities; Allentown, Bethlehem, and Easton. Located one hour north of Philadelphia and 90 minutes west of New York City, the Lehigh Valley is the 69th largest metropolitan region in the United States, with a $37 billion GDP and home to more than 15,000 businesses. The mission of LVEDC is to market the economic assets of the Lehigh Valley and to serve as a regional shared services and resource center to help businesses to come here, start here, and grow here. LVEDC does this by marketing the region nationally to site selectors and companies, providing economic and demographic information, finance and business incentives, site and facility availability, and entrepreneurial and workforce services. The organization is a 501(c)3 organization that works in concert with many regional public and private entities.
#LSF16 | 57
Sponsors MERCK A Legacy of Innovation. Merck has a strong history of success in translating cuttingedge research into life-saving medical breakthroughs. We recognize that building partnerships is one of our most important jobs. In 2015, more than 60% of our human health sales were attributable to alliance partnerships and patents. Strong, lasting alliances are vital to us and to our mission to bring new hope to patients with serious diseases. We believe great drugs begin with a great conversation. We’re interested in any novel approach with robust, scientific data and significant advantages for patients over current therapies — from discovery to late-stage without regard to therapeutic area or modality. When you partner with Merck, you will not only have access to world-class research and development capabilities, but also regulatory, manufacturing, marketing and sales resources to help your discovery reach its full commercial potential—and its full value to society. Learn more at merck.com/licensing.
MORGAN LEWIS Morgan Lewis provides comprehensive transactional and securities, FDA and healthcare, employee benefits, intellectual property and litigation legal services to life sciences clients of all sizes—from just-conceived start-ups, to emerging biotech and medical device companies, to the world’s largest pharmaceutical enterprises. With their strong presence in this region and with substantial offices in Washington, New York, California, Europe and Asia, Morgan Lewis is well-equipped to handle just about every issue that a life sciences company might confront. Over 250 lawyers, scientists and other technical specialists at Morgan Lewis focus everyday on life sciences matters, and they are committed both to understanding the specific business, scientific and regulatory issues that their clients face and to providing practical, value-added counsel and advice.
58 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Sponsors PEPPER HAMILTON Pepper Hamilton LLP is a multi-practice law firm with more than 500 lawyers nationally. The firm provides corporate, litigation and regulatory legal services to leading businesses, governmental entities, nonprofit organizations and individuals throughout the nation and the world. We take a proactive approach to our representation of life sciences companies by organizing around client objectives, and bringing together lawyers with a variety of skills and experience in an interdisciplinary life sciences practice group. This holistic approach enables us to provide comprehensive counseling to life sciences companies at every stage of their corporate development, and every stage of the product life cycle, including discovery, development, manufacturing, marketing and sales. At Pepper, we understand that our clients operate in a heavily regulated and constantly changing environment, which includes escalating business, financing and pricing pressures, as well as the constant threat of government investigations, and commercial, patent and mass tort products liability litigation. Through our experience, we are able to assist clients in navigating complex challenges as they arise, throughout every step in the product life cycle. For more information visit www.pepperlaw.com
PFIZER Good health is vital to all of us, and finding sustainable solutions to the most pressing health care challenges of our world cannot wait. That’s why we at Pfizer are committed to applying science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe, effective and affordable medicines and related health care services to the people who need them. We have a leading portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and we have an industryleading pipeline of promising new products that have the potential to challenge some of the most feared diseases of our time, like Alzheimer’s disease and cancer. To ensure we can continue to deliver on our commitments to the patients, customers and shareholders who rely on us, we are focused on improving the way we do business; on operating with transparency in everything we do; and on listening to the views of all of the people involved in health care decisions. Through working in partnership with everyone from patients to health care providers and managed care organizations to world governments and non-governmental organizations, our goal is to ensure that people everywhere have access to innovative treatments and quality health care.
#LSF16 | 59
Sponsors PHL LIFE PHL Life Sciences is a division of the Philadelphia Convention & Visitors Bureau (PHLCVB), and connects the tri-state’s (Pennsylvania, New Jersey and Delaware) life sciences leaders and influencers representing medical, biotechnology, pharmaceutical, higher education, research, venture capital, and the health care industries to collaborate and brand the Philadelphia region as “America’s Life Sciences Meetings Destination.” We assist with identifying connections to professional societies, associations and meeting planners who are our customers and bring meeting business to our city, and promoting Philadelphia during the decision-making process. We are committed to delivering an exceptional convention experience and connecting attendees with the unique attractions and assets of Philadelphia, especially in medical and life sciences.
PHRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies. Our members are devoted to discovering and developing medicines that enable patients to live longer, healthier and more productive lives. New, innovative medicines are an integral part of the health care system, providing doctors and patients with safe and effective treatment options, and improving quality of life. PhRMA advocates in the United States and around the world for policies that support the discovery and development of those innovative medicines.
PITCH 360 We put aside conventional thinking and perceived limitations and replace them with fresh innovative ideas that create value and return for our clients. Pitch360 Incorporated is a publicity, public relations and marketing communications consultancy that is transforming the way companies communicate to their customers and the mass public. Created with the changing needs of the customer in mind, we use our relationships with a wide variety of stakeholders in the device, pharmaceutical and biotech industry to stay ahead of ‘status quo’ thinking so that we bring forward ideas that rise above that of your competition. Through well established networks of healthcare providers, industry influencers; government, regulatory and policy experts; sports, celebrity, and entertainment groups, as well the healthcare, business, and mainstream media; we have the tools and experience necessary to deliver breakthrough strategies with outstanding results. 60 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Sponsors ROWAN UNIVERSITY SCHOOL OF OSTEOPATHIC MEDICINE
IMPROVING HEALTH THROUGH EDUCATION, RESEARCH AND CLINICAL PRACTICE
To learn more, visit rowan.edu/som
Founded in 1976, Rowan University School of Osteopathic Medicine (formerly the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine) is the only college of osteopathic medicine in New Jersey. Rowan University School of Osteopathic Medicine (RowanSOM) is dedicated to providing excellence in both undergraduate and graduate medical education, research and health care for New Jersey and the nation. As a result of The New Jersey Medical and Health Sciences Education Restructuring Act of 2012, the medical school was integrated with Rowan University on July 1, 2013, becoming the second comprehensive research institution in the state. In addition to our undergraduate and graduate medical education programs, RowanSOM has a robust Graduate School for Biomedical Sciences, and is the leader for biomedical research in Southern New Jersey. Together, Rowan University and its School of Osteopathic Medicine have proven to be a leader in quality education, health care and research.
#LSF16 | 61
Sponsors
Meeting the Life Sciences Industry’s Needs Saul Ewing’s collective background in the sciences, the courts and a wide array of technological realms can help you grow and compete in the Life Sciences Industry.
» www.saul.com D E L AWA R E
MARYL AND
M A S S AC H U S E T T S
NEW JERSEY
N E W YO R K
Deborah L. Spranger, Partner 610.251.5086 dspranger@saul.com Charles M. Lizza, Partner 973.286.6715 clizza@saul.com Kathryn Doyle, Partner 215.972.7734 kdoyle@saul.com William C. Baton, Partner 973.286.6722 wbaton@saul.com P E N N SY LVA N I A
WA S H I N G T O N , D C
Proudly Supports
& The 2016 Annual Life Sciences Future Event
The Wistar Institute Business Development Team is dedicated to advancing Wistar science and technology through creative partnerships. Wistar.org
62 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
#LSF16 | 62
Sponsors SAUL EWING Saul Ewing LLP is a full-service law firm with attorneys who exert national influence on sophisticated matters for businesses across the United States and internationally and we leverage the power of our community connections from working in our 11 offices. This combination of reach and local autonomy supports our clients with the clout of megafirms and the service hallmarks of small boutiques. Our Life Sciences Practice consists of approximately 40 professionals, the majority of whom have direct industry experience – including as scientists, engineers, entrepreneurs and investors. Because we are business people first, we understand that the margins of life sciences companies are being squeezed by increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty. We understand your industry, know the players, and can help you navigate this ever-shifting terrain with legal advice that is practical and business-oriented to guide you in pursuing your business goals.
SHAREVAULT ShareVault offers secure, cloud-based document sharing solutions, also known as virtual data rooms, for organizations of all sizes looking to securely control and monitor highly confidential documents being shared with outside parties. Backed by the experience of billions of dollars in deal transactions, ShareVault’s solutions are used in due diligence for... - Licensing and Partnering - Fundraising and M&A and in other sensitive applications such as ... - CROs and CMOs sharing and protecting their SOPs - Document sharing with consultants, vendors, distributors, Board members and others - Document archiving for sponsor and regulatory audits - University tech transfer licensing processes ShareVault’s robust features together with its wide adoption and recognition in Life Sciences (44 out of the 45 largest pharma have used ShareVault) are just two of many reasons PA Bio, BIO and 40 other regional associations have chosen ShareVault for their member savings programs. It’s also why organizations in 48 countries have trusted ShareVault for their secure document sharing needs.
#LSF16 | 63
Sponsors SHIRE Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal/Internal Medicine/Endocrine and Hereditary Angioedema; and a growing franchise in Oncology. Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.
THE SARIAN GROUP AT HIGHTOWER ADVISORS The Sarian Group at HighTower is a unique consulting firm specializing in serving the leaders and founders of growing life science companies with pre-transaction planning resources to help them keep more of what they have built. Our three step pre-transaction wealth optimization process can help increase your family’s outcome from an exit through valuation enhancement and thoughtful tax planning.
TELEFLEX Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information please visit teleflex.com. Teleflex is the home of Arrow, Deknatel, Hudson RCI, LMA, Pilling, Rüsch, and Weck – trusted brands united by a common sense of purpose.
64 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Sponsors TEMPLE UNIVERSITY Temple University is a comprehensive public research university with 17 schools and colleges and 38,000 students. With more than $236 million in annual research expenditures, Temple University is advancing cutting-edge technologies through an active technology development program, including a new startup accelerator, Temple Ventures—Powered by Ben Franklin. Temple discoveries in the marketplace include diagnostic tests for chronic fatigue syndrome, instruments for the diagnosis and treatment of tooth decay, and pheromone attractant technology for pest control. Products in the pipeline include phage technology to treat antibiotic-resistant bacteria, next-generation disinfectants, therapeutics for heart disease and inflammatory bowel syndrome, and diagnostics for viruses, cancer and COPD. Through continued advancement of the university’s research enterprise, Temple is ensuring its place as a nexus of discovery, education, translational research and service, dedicated to improving quality of life and expanding our understanding of the world for the benefit of society.
T:7.75”
Our purpose is clear: to make a difference in the lives of those living with and affected by rare diseases and highly specialized conditions.
For more information, please visit shire.com
INTSP/C-ANPROM/CORP/16/0022
S13862 05/16
#LSF16 | 65
T:5”
Unmet needs require unmatched commitment.
Sponsors TEVA Teva Pharmaceuticals is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva’s net revenues in 2015 amounted to $19.7 billion. For more information, visit www. tevapharm.com
THOMAS JEFFERSON UNIVERSITY Under President and CEO Dr. Stephen K. Klasko’s leadership, Jefferson Health has grown from 3 hospitals to 12, making Jefferson Health System the largest provider of outpatient and inpatient services in the marketplace. The foundation of this enterprise consists of 4 Pillars: Clinical, Academic, Institutional Advancement, & Innovation. The Innovation Pillar focuses on transforming the entire healthcare experience, and infuses its learning into future health professionals. Dr. Rose Ritts, Executive Vice President of the Innovation Pillar and Chief Innovation Officer, leads a team headed by Robin Sheldon, Vice President of Innovation Management, that is dedicated to creating an entrepreneurial ecosystem to advance the commercialization of new health related technologies. The Innovation Pillar tests new business models and nurtures entrepreneurialism among employees, students and others in the Jefferson community. The Innovation Pillar looks for new forms of value creation, and thus, focuses on commercialization of in three areas: (i) technologies that emanate from the Jefferson community (a Spin-Out), (ii) companies created outside of Jefferson but desire Jefferson’s experience to advance the technology (a Spin-In), and (iii) identifying offerings that solve a Jefferson need and have utility for others (a Spin-Up).
66 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Sponsors UNIVERSITY CITY SCIENCE CENTER Located in the heart of uCity Square, the University City Science Center is a dynamic hub for innovation, entrepreneurship and technology commercialization. For more than 50 years, we have helped scientists, entrepreneurs, startups, and growing and established companies throughout the Greater Philadelphia region as they move their technologies into the marketplace, where they can benefit the world. By convening entrepreneurs, connecting them to investors and advice, and helping them bring their ideas to market, we’re helping to grow the region’s economy – one idea, and one job, at a time. Graduate firms and current residents of the Science Center’s business incubator support one out of every 100 jobs in Greater Philadelphia and drive $13 billion in economic activity in the region annually. For more information visit ScienceCenter.org
UNIVERSITY OF THE SCIENCES University of the Sciences has been propelling innovation for nearly 200 years since its founding in 1821 as Philadelphia College of Pharmacy, the first college of pharmacy in North America. Today, USciences is home to more than 30 degree-granting programs from bachelor’s through doctoral degrees in bench and health sciences, ranging from cancer biology to healthcare business and policy to pharmacology and toxicology. Throughout its history, USciences has produced an abundance of pioneers—trailblazers in scientific discovery, daring entrepreneurs, and compassionate leaders in the healing professions. Our alumni have contributed to innovation in every dimension of the health sciences, from pioneering the use of x-rays to unlocking the genetic code to discovering countless new medications. Recent graduates have continued this legacy as founders of pharmaceutical companies and companies serving the biotech and life sciences industries. Key to our distinctive education is a tradition of hands-on research. We value an environment that incorporates integrative academics and clinical practice, melds clinical practice research with basic research, and fosters more meaningful interaction between students and faculty. As careers in healthcare and science continue to grow, a USciences’ education not only makes for a rewarding choice, but an investment in the future. That’s why USciences graduates are proven everywhere they go.
#LSF16 | 67
Sponsors UNIVERSITY OF PENNSYLVANIA The Penn Center for Innovation (PCI) translates Penn discoveries and ideas into new products and businesses for the benefit of society by facilitating connections with the private sector. Whether the end result is a technology license, an R&D alliance, the formation of a new venture, or an integrated combination of these activities, PCI serves as a dedicated one-stop shop for commercial partnering with Penn.
UNIVERSITY OF PITTSBURGH At the confluence of world-class education and research at the University of Pittsburgh is a deep undercurrent of innovation and entrepreneurship. From the discovery of the polio vaccine by Dr. Jonas Salk to Dr. Thomas Starzl’s pioneering of the field of organ transplantation, Pitt innovators have had a profound impact on our world. On the strength of $760 million in annual sponsored research, the next generation of Pitt Innovators is making exciting discoveries in areas ranging from cancer detection and treatment to gene therapy, drug discovery and delivery, medical devices, regenerative medicine, advanced materials, nanoscience, bioengineering, energy, education, and more. Translating that research for real world impact, Pitt innovators have been issued nearly 260 patents since FY’12, and the university has executed 570 licenses/options. The Innovation Institute provides a comprehensive suite of services, from patenting intellectual property to the commercialization of new discoveries through licensing and/or new enterprise development. The Institute also provides a wealth of educational programming, mentoring and networking for Pitt faculty, students and partners, as well as for entrepreneurs and small businesses throughout Western Pennsylvania. For the Innovation Institute to achieve its mission, it needs strong partners to evaluate and license Pitt technologies and to help finance and mentor start-up companies. To partner with Pitt innovators and help them invent the future, contact the Innovation Institute at innovate@ pitt.edu, or visit www.innovation.pitt.edu. Follow us on Twitter: @PittInnovates. 68 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Sponsors VERTEX Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. Founded in 1989 in Cambridge, Mass. and headquartered in Boston’s Innovation District, Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. Read more about our global locations. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases. Read more about our approved medicines and pipeline. We collaborate with some of the world’s largest pharmaceutical companies, leading nonprofit disease foundations and many of the world’s best-known academic institutions.
THE WISTAR INSTITUTE The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the country, Wistar has held the prestigious National Cancer Institute Cancer Center designation since 1972. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. Wistar’s Business Development team is dedicated to advancing Wistar Science and Technology Development through creative partnerships. wistar.org
#LSF16 | 69
Volunteers Steven Bass
Marc Prine
Joe Batastini
Cheryl Roche
Ron Bean
Jen Salvucci
Mary Buatti-Small
Dale Schwesig
Sharlene Cirillo
Kathleen Shelmerdine
Joan Corrado
Eddie Stewart
Carrie Davis
David Tierney
Chris DeMerlis
Earl Whipple
Debbie Fabian
John Williams
Mike Forese
Amelia Zellander
Michael Gamble John Hamill Paul Hart Hannah Hartwell Lorraine Haslip Dave Janzow Erin Killeen Kenneth Kirsch Marie Kraft Kate Madden Terri Madden Michelle Mathis -Scott Andrew Meadows Eleanore Meals Kevin O’Neill Ed Oxenham Kim Pagliaro-Bussard
70 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
thank you to our 2016 volunteers!
GROUNDED IN RESEARCH. PREPARED FOR REALITY. P ROV E N E V E RY W H E R E T H E Y G O. University of the Sciences has a rich legacy of producing innovators in science and healthcare since its founding in 1821 as North America’s first college of pharmacy. With a tradition of hands-on research, USciences has produced pioneers in scientific discovery, daring entrepreneurs, compassionate leaders in healing professions, and founders of innovative pharmaceutical companies. Our graduates are prepared today for a rewarding future and proven everywhere they go.
usciences.edu/PABio
Teva Pharmaceuticals is a proud sponsor of the 2016 Life Sciences Future event
Acquisitions – Integral to Strategy Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care.
T
Acquisition Opportunities, Contact: Michael Probst, Director of Corporate Development Michael.Probst@Teleflex.com 610.225.6922
and generic pharmaceuticals, Teva provides both new and innovative therapies and greater access to affordable medicines.
Teleflex Incorporated • 550 E. Swedesford Road • Suite 400 Wayne, PA 19087-1603 USA www.teleflex.com
eva Pharmaceuticals is working every day to make quality healthcare accessible. As a manufacturer of specialty
tevausa.com
Teleflex is a registered trademark of Teleflex Incorporated or its affiliates. © 2016 Teleflex Incorporated. All rights reserved.
Planning Committee Volunteer
Organization
Volunteer
Organization
Laurie Actman
University of Pennsylvania
Kristin Liezenga
KinderPharm
Lee Ann Shiveley
Tungsten Strategy
Marc Malandro
University of Pittsburgh Innovation Institute
Christian Barrow
JPMorgan
Christian Manders
Promethean LifeSciences, Inc.
Travis Bliss
Buchanan Ingersoll & Rooney
Alice Marcy
Dynamis Therapeutics
Jerry Bollenbach
Deloitte
Jean Marie Markham
Clinlogix
Greg Bosch
Geistlich Pharma
Keith Marmer
SG3 Ventures
Kimberly Bradley
GlaxoSmithKline
Alex Martin
PuriCore, Inc.
Erin Brubaker
GlaxoSmithKline
Jeff Martini
Teva Pharmaceuticals
Lisa Caperelli
Marinus Pharmaceuticals
Kevin McMonagle
RSM
David Chapman
Teva Pharmaceuticals
Brian McVeigh
GlaxoSmithKline
Hal Craig
Trout Creek Consulting, LLC
Tony Meehan
TetraLogic Pharmaceuticals
Charles Dormer
APEXSTP, LLC
Joe Messina
JPM Biopartnering Pharma, LLC
Kathryn Doyle
Saul Ewing LLP
Christopher Mikson
Mayer Brown
Donna Eash
Frontage Laboratories
Larry Miller
Innovation Works
Richard Gilly
Offit Kurman
Judith Millsaps
TayganPoint Consulting Group
Bonnie Grant
PHL LifeSciences
Dora Mitchell
Penn Center for Innovation
Sean Grim
Joulé
Steve Nappi
Temple University
Lorraine Haslip
Biocoat
Kuldeep Neote
Janssen Biotech, Inc
Thomas Hess
Genomind, Inc.
Michael O’Gorman
Clinlogix
Robb Hoyle
Growth Technical Staffing
Kim Pagliaro Bussard
Advanced Staging Productions
Francis Humann
OncoViRx
John Pennett
EisnerAmper
Charlie Huntington
Huntington/Kraus Financial Group
Nancy Richardson
Velocity BioGroup
Lauren Kaskiel
Spark Therapeutics
John Rigaut
JTR & Associates, LLC
Brian Kenney
Janssen Research & Development
Jeannie Rojas
Janssen Biotech, Inc.
Steve Kraus
Huntington/Kraus Financial Group
Mike Romano
RSM US LLP
Stephanie Kuhla
Advanta Advertising, LLC
David Sadowski
Penn State Hershey
Matt Levy
Velocity Advisory Group
Sandra Saouaf
Atlantic Bio Sci, LLC
72 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
Volunteer
Organization
Volunteer
Organization
Greg Sarian
The Sarian Group at HighTower
Debra Travers
POLYAURUM LLC
Cary Schockemoehl
PuriCore, Inc.
Doreen Trujillo
Saul Ewing
Jay Scott
Alex’s Lemonade Stand Foundation
David U’Prichard
Druid Consulting
Michael Seggev
SeggevM Consulting LLC
Kyle Vos Strache
Cozen O’Connor
Kate Shay
Duane Morris
Jordan Warshafsky
Ashton Tweed LTD
Patrick Shea
Egalet
Michele Washko
Geisinger
Kenny Simansky
Drexel University
Justin Watkins
Drinker Biddle & Reath LLP
Steve Simpson
Ernst & Young
Thomas Wescott
Javan Engineering, Inc.
Sally Smith
Joulé
Alan West
Carmell Therapeutics
Sean Stadelman
Goldberg Segalla, LLP
Seth Whitelaw
Whitelaw Compliance Group, LLC.
Eileen Sullivan-Scully
LZ Lifescience
Oz Whitesell
MKJ
John Swartley
Penn Center for Innovation
Jennifer Young
Pittsburgh Technology Council
Erika Swift
Penn State Hershey
Kyle Youtz
Growth Technical Staffing
Gretchen Temeles
Duane Morris LLP
Anthony Zecca
Celero
#LSF16 | 73
Board of Directors STEPHEN ALLAN
MAXINE GOWEN, PH.D.
Sr. Vice President Strategic Planning
President & CEO
Unilife Medical Solutions
Trevena, Inc.
ARMANDO ANIDO
BRIAN HALAK, PH.D.
Chairman of the Board & CEO
Partner
Zynerba Pharmaceuticals
Domain Associates
NEIL CAMPBELL
MICHAEL HOERRES
President & CEO
Chief Executive Officer
Helomics Corporation
Cernostics, Inc.
CHRISTOPHER CASHMAN
JOHN HUBBARD, PH.D., FCP
President & CEO
President & CEO
Marinus Pharmaceuticals
BioClinica, Inc.
JAMES DATIN
DENNIS JACKMAN
President & CEO
SVP, Global Healthcare Policy & External Affairs
BioAgilytix Labs
CSL Behring
BRIAN DOERNER
JOSEPH LA BARGE
Partner
Head of Business Administration and General Counsel
Ballard Spahr LLP
Spark Therapeutics, Inc.
MATTHEW GANTZ
MAHMOOD LADHA Head of US Business Operations AstraZeneca Pharmaceuticals
GLEN GAULTON, PH.D.
DAVID LEDBETTER, PH.D., FACMG
Vice Dean & Director for the Center of Global Health
Executive Vice President & Chief Scientific Officer
University of Pennsylvania
Geisinger Health System
74 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA
TERRI LEE
JOHN SCHUELER
Vice President, Government Affairs
Chief Operating Officer
Merck & Co, Inc.
Fujirebio Diagnostics, Inc.
JEFFREY LIBSON
KATHLEEN SHAY
SECRETARY
Partner
Partner
Duane Morris LLP
Pepper Hamilton LLP
MARC MALANDRO, PH.D., CLP
BRUCE SHOOK
CHAIRMAN
President & CEO
Founding Director
Intact Vascular, Inc.
University of Pittsburgh
CHRISTIAN MANDERS
STEPHEN SIMPSON
Chief Operating Officer
Partner, Strategic Growth Markets
Promethean LifeSciences
Ernst & Young, LLP
BRIAN MCVEIGH
ROBERT SMITH
Vice President, Worldwide Business Development Transactions & Investment Mgmt.
Sr. Vice President, Worldwide Business Development, Worldwide Research & Development & Strategic Transactions
GlaxoSmithKline
Pfizer Inc.
VINCENT MILANO
RONALD SPAIR
TREASURER
COO & CFO
Chief Executive Officer
OraSure Technologies, Inc.
Idera Pharmaceuticals, Inc.
CHRISTOPHER MOLINEAUX
PERRY STERNBERG
PRESIDENT & CEO
Head of US Commercial
President & CEO
Shire Pharmaceuticals
Pennsylvania Biotechnology Association
ROBERT RADIE
JENNIFER STRONG
President & CEO
Partner
Egalet Pharmaceuticals
KPMG LLP
#LSF16 | 75
Board of Directors STEPHEN TULLMAN
BRYAN WOLF, M.D., PH.D.
Managing Partner
Executive Vice President & Chief Scientific Officer
NeXeption
The Children’s Hospital of Philadelphia
NEAL WALKER, D.O.
MICHAEL YANG
President & CEO
President, Immunology
Aclaris Therapeutics
Janssen Biotech, Inc.
ALAN WEST
STEPHEN YODER, M.D., MBA
Chief Operating Officer
Head, Specialty Pharmaceuticals Search & Evaluation Business Development
Carmell Therapeutics
Bristol-Myers Squibb
76 | LIFE SCIENCES FUTURE | OCTOBER 25-26, 2016 | PHILADELPHIA, PA